Form 8-K - Current report:
SEC Accession No. 0001193125-21-017700
Filing Date
2021-01-26
Accepted
2021-01-26 16:12:01
Documents
14
Period of Report
2021-01-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d26439d8k.htm   iXBRL 8-K 27252
2 EX-99.1 d26439dex991.htm EX-99.1 7666
6 GRAPHIC g26439g0126114244253.jpg GRAPHIC 1595
  Complete submission text file 0001193125-21-017700.txt   164133

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20210126.xsd EX-101.SCH 3102
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20210126_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20210126_pre.xml EX-101.PRE 11429
7 EXTRACTED XBRL INSTANCE DOCUMENT d26439d8k_htm.xml XML 3341
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 21554184
SIC: 2834 Pharmaceutical Preparations